Industrialization, Integration, and Digitalization - Industry Insiders Talk Together on Technology Innovation to Help Healthy China
2023-09-04
Surgical robots make surgeries more precise and efficient. Smart wards provide full process services to patients from call warning, infusion monitoring, vital sign monitoring, and other aspects... In recent years, the integration of artificial intelligence and digital medicine has helped patients enjoy more efficient and convenient services. How can medical industry integration empower industrial development? How can technological innovation contribute to a healthy China? As one of the series of peak forums held during the 2023 China International Trade in Services Fair, the 2023 Health and Pharmaceutical Industry Innovation Service Conference, jointly organized by the Ministry of Industry and Information Technology, the National Health Commission, and the Beijing Municipal People's Government, was held in Beijing on the 3rd. Guests gathered together to discuss "health", delving into the forefront of medical industry integration innovation and industrial chain collaborative innovation, and providing wisdom and suggestions for the construction of a healthy China. The biopharmaceutical industry is a strategic emerging industry that is related to the national economy, people's livelihood, and national security. Strengthening basic research and technological innovation capacity construction is crucial for the high-quality development of the biopharmaceutical industry. At present, a new round of technological revolution and industrial transformation is deepening, the new generation of biotechnology is becoming increasingly mature, the global pharmaceutical industry pattern is deeply adjusted, residents' health consumption is upgrading, and innovative development in the pharmaceutical field has ushered in broader prospects and space. "Wang Jiangping, Deputy Minister of Industry and Information Technology, said. He stated that we should make every effort to create a collaborative development ecosystem for the pharmaceutical industry, promote the industrialization of pharmaceutical innovative products, support enterprises to strengthen the layout of innovative drug research and development with new targets, mechanisms, and types, deepen the implementation of the pharmaceutical industry supply chain strengthening project, accelerate the digital transformation of the pharmaceutical industry, and promote the application of artificial intelligence, cloud computing, big data, and other technologies in the field of pharmaceutical research and development to better meet the diverse needs of the public Multi level health needs. Zeng Yixin, Deputy Director of the National Health Commission, said that there are still certain shortcomings in the innovative development of medicine, medical treatment, equipment, and industrial technology. We need to seize opportunities, build a healthier and more efficient biopharmaceutical technology innovation ecosystem, further play the supporting role of technological innovation strategy, focus on promoting the integrated layout of education, especially talent, and continuously improve China's biopharmaceutical level. Building a national biopharmaceutical laboratory and various key laboratories, implementing a special project for medical and health talents, establishing the Capital Medical Science and Technology Achievement Transformation Public Welfare Fund, and issuing an open policy covering the entire industry chain from research and development to clinical application... Sun Meijun, a member of the Standing Committee of the Beijing Municipal Committee and Minister of Organization, introduced that Beijing has taken a series of measures to strengthen the collaborative innovation and development of the pharmaceutical industry and medical industry, and actively layout AI healthcare Emerging fields such as digital healthcare. At the meeting, the "2022 China Pharmaceutical Enterprise R&D Index" was released to provide reference for relevant enterprises and institutions in the industry to enhance their technological innovation capabilities. Jiang Lingfeng, Vice Chairman of Chongqing Zhifei Biological Products Co., Ltd., said that innovation is the "new engine" and strong driving force for high-quality development of enterprises. By seizing innovation, one can grasp the "bull nose" that affects the overall high-quality development of enterprises. The company will continue to place innovation at the core of its overall development, continuously optimize the layout of important pharmaceutical material production capacity, fill the gaps in high-end supporting industries, and enhance its key core competitiveness. The reporter learned that during this year's Service Trade Fair, Jian, located in Hall 3 of Beijing Shougang Park
Edit:Hu Sen Ming Responsible editor:Li Xi
Source:XinhuaNet
Special statement: if the pictures and texts reproduced or quoted on this site infringe your legitimate rights and interests, please contact this site, and this site will correct and delete them in time. For copyright issues and website cooperation, please contact through outlook new era email:lwxsd@liaowanghn.com